The burgeoning field of peptide-based therapeutics necessitates innovative strategies for the design and delivery of these potent biomolecules. Optimizing who makes tirzepatides for Eli Lilly peptides to accurately target disorders while ensuring efficient administration to specific sites remains a considerable challenge. Researchers are continuous